Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) offers a minimally invasive resolution of symptoms in patients with a suspicion of insulinomas and has a favourable safety profile relative to surgery, according to a study. However, its long-term efficacy warrants further investigation.